Wei Lu

18PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersChemotherapyMicro- and nanosystemsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 08, 2026
FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate.

|Feb 26, 2026
Self-Assembled Nanoparticles with Kynureninase-Fc Fusion Protein and Pheophorbide A for Photodynamic Immunometabolic Cancer Therapy.

Chen Zhang, Afeng Yang, Hongzheng Lin

|Sep 05, 2025
Engineered Substrate-Free Small Molecules for Enhanced Raman Scattering and Photothermal Conversion Efficiency.

Sheng Yu, Shuai Gao, Yongming Zhang

|Jan 21, 2025
CD133<sup>+</sup>PD-L1<sup>+</sup> cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma.

Jiaojiao Xu, Zhe Li, Qinli Tong

|Jan 08, 2025
Gemcitabine-Loaded Microbeads for Transarterial Chemoembolization of Rabbit Renal Tumor Monitored by <sup>18</sup>F-FDG Positron Emission Tomography/X-Ray Computed Tomography Imaging.

Xiaoli Zhang, Tingting Li, Jindong Tong

|Dec 20, 2024
A Near-Infrared-II Fluorescent Nanoprobe Offering Real-Time Tracking of Fenton-Like Reaction for Cancer Chemodynamic Theranostics.

Jingwen Sun, Shuai Gao, Guoguang Wei

Pageof 3

Frequent Collaborators

6 joint publications

Zeyu Xiao

2 joint publications

Ai-Jun Sun

2 joint publications

Cheng-Chao Ruan

1 joint publications

Jian-Bo Wan